Free Trial

The Biotech Growth Trust (LON:BIOG) Share Price Passes Below 50-Day Moving Average - Here's Why

The Biotech Growth Trust logo with Financial Services background
Remove Ads

Shares of The Biotech Growth Trust PLC (LON:BIOG - Get Free Report) passed below its fifty day moving average during trading on Monday . The stock has a fifty day moving average of GBX 823.62 ($10.79) and traded as low as GBX 726 ($9.51). The Biotech Growth Trust shares last traded at GBX 754 ($9.88), with a volume of 503,509 shares.

The Biotech Growth Trust Trading Down 3.4 %

The company has a quick ratio of 0.00, a current ratio of 0.59 and a debt-to-equity ratio of 11.02. The business's fifty day moving average is GBX 816.38 and its 200-day moving average is GBX 905.72. The stock has a market capitalization of £195.98 million, a PE ratio of 2.30 and a beta of 0.50.

Insider Activity

In other The Biotech Growth Trust news, insider Nicola Shepherd bought 1,000 shares of the company's stock in a transaction that occurred on Monday, January 13th. The stock was purchased at an average price of GBX 846 ($11.08) per share, with a total value of £8,460 ($11,084.91). Corporate insiders own 0.71% of the company's stock.

About The Biotech Growth Trust

(Get Free Report)

The Biotech Growth Trust seeks capital appreciation through investment in the worldwide biotechnology industry. In order to achieve its investment objective, the Company invests in a diversified portfolio of shares and related securities in biotechnology companies on a worldwide basis. Performance is measured against the NASDAQ Biotechnology Index (sterling adjusted).

See Also

Should You Invest $1,000 in The Biotech Growth Trust Right Now?

Before you consider The Biotech Growth Trust, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and The Biotech Growth Trust wasn't on the list.

While The Biotech Growth Trust currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

The 10 Best AI Stocks to Own in 2025 Cover

Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.

Get This Free Report
Like this article? Share it with a colleague.
Remove Ads

Featured Articles and Offers

Recent Videos

3 Stocks to Buy on the Dip—and 3 to Dump Fast
Trump Tariffs Tumble the Stock Market—Here’s How to Protect Your Money
Donald Trump Owns These 7 Stocks, Should You?

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines

Remove Ads